Search:

Medical Pharmaceuticals Headlines from PR Newswire


< Go Back

Jazz Pharmaceuticals Receives FDA Approval For Intravenous Administration Of Erwinaze® (asparaginase Erwinia chrysanthemi)
Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making
Building a Best-in-Class Pharma Global Brand Website
AbbVie Receives U.S. FDA Approval of VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C
Root Canals Have Become More Routine
Hospira to Present at the J.P. Morgan 33rd Annual Healthcare Conference Jan. 14, 2015
XYDALBA™ (dalbavancin) Receives CHMP Positive Opinion for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Adults
U.S. Contrast Agent and Radiopharmaceutical Market Will Grow Modestly Through 2023
Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023
Hospira Foundation Announces The Leukemia & Lymphoma Society as Winner of $100,000 (Mission: Care)2 Grant
Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd.
Origins Behavioral Healthcare To Acquire Hanley Center, Gate Lodge
Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner
Aegate Appoints new CTO and Chief Channels & Partner Officer
2015 iaedp Symposium Presents the Latest in Eating Disorder Treatment with the Country's Top Professionals
USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT
Bina Technologies is acquired by Roche.
Roche acquires Bina Technologies and enters the genomic informatics market
The Global In-Situ Hybridization Market is Expected to Grow at a CAGR of 11.7% from 2014 to 2019
Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference
Down But Not Out: Joint Pain Doesn't Mean The End Of A Soldier's Career
Wounds Therapeutic Pipeline H2 2014 Review in New Market Research Report
Seven More Research Organizations Earn AAHRPP Accreditation, Including First in Thailand
X-Ray Detectors Market Worth $2,552.7 Million by 2019
Cardio3 Biosciences Announces the Enrolment of the 240th Patient for its CHART-1 Phase III Clinical Trial for the Treatment of Heart Failure
Mount Sinai Health System and Valley Health System Announce Strategic Alliance
Novogen Raises An Additional A$1.75m in Private Placement to US Institutions for Aggregate Private Placement of A$5.85m
Veloxis Comments on U.S. District Court Order
CBD Oil Comparable to Charlotte's Web Ready to be Produced by American Farmers
Son of a Mesothelioma Victim Shows Veterans with Mesothelioma How to Get the Right Answers, Right Away
CarePoint Health - Hoboken University Medical Center Awarded Coveted 2014 Leapfrog Top Hospital Distinction
Global Anesthesia Machine Industry, China Veterinary Anesthesia Machines 2014-2019 Reports
Actavis to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
Aeterna Zentaris Receives Notification from NASDAQ Relating to Minimum Bid Price
Two-Time Cancer Survivor and Musician Mike Peters Emerges as New Leader for Cancer Survivor Community at World Cancer Congress 2014
Blackrock Microsystems Launches Wireless Brain Research System
Halozyme Receives European Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer
Xarelto Attorney News Update: U.S. Judicial Panel Has Centralized Xarelto Lawsuits Filed Nationally in Louisiana
La Jolla Cosmetic Surgery Centre Welcomes New Board Certified Plastic Surgeon
Soligenix Announces Pricing of Public Offering of Units
MedSpring Urgent Care Opens Location in San Marcos, Texas
Phonak Launches U.S. Audiology Research Center
Translarna Granted Orphan Drug Designation in the U.S. and Europe for the Treatment of Mucopolysaccharidosis I
OncoGenex Announces Results from the Phase 2 Borealis-1™ Trial of Apatorsen in the Treatment of Metastatic Bladder Cancer
Cardiome Enters Development and Commercialization Agreement with Eddingpharm for BRINAVESS™ in China
NxStage Founder and CEO Discusses Innovation in Healthcare at EY Boston Life Sciences Summit
Australian presence of Elekta's Versa HD radiation therapy system grows
CHMP Recommends Approval of Xadago™ (Safinamide) to Treat Parkinson´s Disease in the EU
Orexigen's Mysimba™ (naltrexone HCl / bupropion HCl prolonged release) Receives Positive CHMP Opinion Recommending Approval for Weight Management in the European Union
Sales of CT Systems Near 3.9 Billion: Report

< Prev Next >
PR Newswire - United Business Media